Researchers get to the bottom of noninvasive gut tests
New research from the University of British Columbia Okanagan, recently published in the Journal of Biological Chemistry could make monitoring gut health easier and less painful by tapping into a common — yet often overlooked — source of information: the mucus in our digestive system that eventually becomes part of fecal matter.
Correct, what’s in our poop.
Biology researcher Kirk Bergstrom and master’s student Noah Fancy found a noninvasive technique to study MUC2, a critical gut protein, from what we leave behind in the bathroom.
“MUC2 is like the silent star in our guts. It’s constantly working to protect us, and its proper functioning is crucial for our overall health,” Bergstrom said. “It was originally thought that you could only access this important molecule from biopsies or tissue removed via surgery — highly invasive and painful procedures.
“However, our study shows mucus is actually a part of our stool, meaning we can get at it painlessly and at levels we could not before. Anytime we can do analysis noninvasively, it’s a win.”
Clues to health can be found in unexpected places, and Bergstrom’s team found a way to study important gut health markers from fecal-adherent mucus — a term that, in simpler words, refers to the mucus attached to our stool. This mucus, typically ignored and flushed away, contains a trove of information about gut health.
MUC2, a glycoprotein with many sugar chains attached, forms a protective barrier in our intestines in the form of mucus, safeguarding our gut from harmful microbes and toxins and playing a crucial role in digestive health.
Understanding MUC2 better could lead to significant advancements in managing and preventing gut-related diseases, impacting the day-to-day well-being of millions.
“We can use these new methods to visualize mucus–microbiota interactions and how they go wrong in various diseases, like inflammatory bowel diseases and colon cancer,” Bergstrom noted. “The sugars on the mucins also carry lots of information on the health status of the colon.”
Fancy led the work, which was the result of a strong collaborative effort between the Bergstrom Lab and the chemistry lab of Wesley Zandberg and the biology labs of Sepideh Pakpour, Deanna Gibson and Sanjoy Ghosh, all at UBC Okanagan.
This article was originally published in the UBC Okanagan News. You can read the original here.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.